An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for MIRATI THERAPEUTICS Inc
| Ticker | MRTX |
| FIGI | BBG004TPGBP5 |
| CUSIP | 60468T105 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 3 / 0.0% |
| Number of Shares | 3.2 mil. |
About
Mirati Therapeutics, Inc. is an American targeted oncology company that focuses on the development of cancer therapeutics. Bristol Myers Squibb acquired the company in January 2024. Wikipedia